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Differential gene expression in Ndph knockout mice in retinal
development
Abstract
PURPOSE. Mutations in the NDP gene impair angiogenesis in the eyes of patients diagnosed with a
type of blindness belonging to the group of exudative vitreoretinopathies. With this study, we aimed to
investigate differential gene expression caused by the absence of Norrin (the NDP protein) in the
developing mouse retina to elucidate early pathogenic events. METHODS. A comparative gene
expression analysis was performed on p7 (postnatal day 7) retinae from a knockout mouse model for
Norrie disease using Affymetrix microarrays. Subsequently, results were verified by quantitative
real-time PCR analyses. Immunohistochemistry was performed for the vascular permeability marker
Plasmalemma vesicle-associated protein (Plvap). RESULTS. Our study identified expression
differences in Ndph(y/-) vs. wild type mice retinae at p7. Gene transcription of the neutral amino acid
transporter Slc38a5, apolipoprotein D (ApoD) and angiotensin II receptor-like 1 (Agtrl1) was decreased
in the knockout, whereas transcript levels of adrenomedullin (Adm) and of the plasmalemma vesicle
associated protein (Plvap) were increased in comparison to the wild type. In addition, we found ectopic
expression of Plvap in the developing retinal vasculature of Norrin knockout mice on the protein level.
CONCLUSIONS. These data provide molecular evidence for a role of Norrin in the development of the
retinal vasculature. Expression of two genes, Plvap and Slc38a5, is considerably altered in retinal
development of Norrin knockout mice and may reflect or contribute to the pathogenesis of the disease.
In particular, ectopic expression of Plvap is consistent with hallmark disease symptoms in mouse and
man.
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PURPOSE. Mutations in the NDP gene impair angiogenesis in the eyes of patients diagnosed 
with a type of blindness belonging to the group of exudative vitreoretinopathies. With this 
study, we aimed to investigate differential gene expression caused by the absence of Norrin 
(the NDP protein) in the developing mouse retina to elucidate early pathogenic events. 
 
METHODS. A comparative gene expression analysis was performed on p7 (postnatal day 7) 
retinae from a knockout mouse model for Norrie disease using Affymetrix microarrays. 
Subsequently, results were verified by quantitative real-time PCR analyses. 
Immunohistochemistry was performed for the vascular permeability marker Plasmalemma 
vesicle-associated protein (Plvap). 
 
RESULTS. Our study identified expression differences in Ndphy/- vs. wild type mice retinae at 
p7. Gene transcription of the neutral amino acid transporter Slc38a5, apolipoprotein D (ApoD) 
and angiotensin II receptor-like 1 (Agtrl1) was decreased in the knockout, whereas transcript 
levels of adrenomedullin (Adm) and of the plasmalemma vesicle associated protein (Plvap) 
were increased in comparison to the wild type. In addition, we found ectopic expression of 
Plvap in the developing retinal vasculature of Norrin knockout mice on the protein level. 
 
CONCLUSIONS. These data provide molecular evidence for a role of Norrin in the 
development of the retinal vasculature. Expression of two genes, Plvap and Slc38a5, is 
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considerably altered in retinal development of Norrin knockout mice and may reflect or 
contribute to the pathogenesis of the disease. In particular, ectopic expression of Plvap is 
consistent with hallmark disease symptoms in mouse and man. 
Key words: Vitreoretinopathy • Angiogenesis • Gene expression • Norrie Disease • Ndph • Plvap 
 
 
INTRODUCTION 
 
Norrie Disease (OMIM 310600; ND) is an X-linked, recessive neurological disorder that 
presents with congenital blindness, progressive deafness and mental retardation1, and is 
caused by mutations in the Norrie disease pseudoglioma (NDP) gene2,3,4. The high phenotypic 
variability even within one family carrying the same mutation5,6,7 suggests the involvement of 
modifier genes or other factors, which might explain why no clear genotype-phenotype 
correlation has been described so far. In addition, mutations in this gene have also been 
associated with a variety of other recessive and sporadic vitreoretinal diseases, including 
exudative vitreoretinopathy (OMIM 133780; EVR), retinopathy of prematurity (ROP, stages 
4b and 5) and Coats’ disease (OMIM 300216)8,9,10,11. These allelic clinical entities show 
remarkable similarities in their ocular phenotype especially with regard to abnormalities in the 
retinal vasculature.  
The human disease phenotype is strongly resembled by the Norrie disease pseudoglioma 
homolog (Ndph) knockout mouse12,13. Although the retinal vasculature in humans develops 
around mid-gestation, and only postnatally in mice, the timing of events is comparable. In 
mice, retinal blood vessels start to develop around birth at the optic disc and spread radially 
inside the nerve fiber layer across the retina, until they reach the periphery around postnatal 
day 9 (p9). In addition, vessels start to sprout into the deeper layers of the retina at p7 to form 
two additional networks in the plexiform layers, parallel to the superficial plexus. Contrary to 
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the development of the retinal vasculature, the hyaloid vessel system, a transient 
developmental vasculature nourishing the developing lens, regresses. This process starts after 
its peak extension around p5 and lasts until p15, around which time the mice open their eyes 
and eye development is more or less complete14. In the Ndph knockout mouse, the inner 
retinal vessel development is severely impaired. The outgrowth of the superficial retinal 
vessel plexus is delayed and remains sparse, deep retinal vessels do not develop, and the 
regression of the hyaloid vasculature is delayed and incomplete. Furthermore, disorganization 
of the retinal ganglion cell layer and a reduction of retinal ganglion cells have been 
described12,15,13. However, proliferation of fibrovascular material in the vitreous cavity is not 
as massive as the pseudoglioma described in patients suffering from severe ND. 
Different hypotheses have been postulated about the etiology of these symptoms. It has been 
discussed that the extended presence of hyaloid vessels might impair the development of the 
retinal vasculature16,17. However, blockage of the placental growth factor (PlGF) during early 
postnatal stages in the eye leads to delayed regression of the hyaloid vessel system, but not to 
changes in the retinal vasculature18, indicating that persistence of the hyaloidea does not 
necessarily lead to defects in or lack of retinal vascularization. Another hypothesis was 
provided by a detailed analysis of the early development of the retinal vasculature in Ndph 
knockout mice, which suggested two phases of disease progression in vivo15: In the early 
phase, the absence of functional Norrin (Ndph–protein) causes a defect in sprouting 
angiogenesis, which leads to a delayed outgrowth of the superficial vessels and prevents the 
formation of deep capillary networks in the retina. Then, in the later phase, the developmental 
lack of the deep vasculature leads to inner retinal hypoxia. This pathologic hypoxia may 
explain the observed clinical features of Norrie disease and might also be responsible for the 
similarities of the clinical phenotypes of the aforementioned diseases15. In another study, the 
knockout phenotype could be rescued by ectopic overexpression of Norrin in the lens19. Their 
authors suggested a direct effect of Norrin on vascular proliferation, since proliferation of 
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microvascular endothelial cells was increased after co-cultivation with the Norrin-expressing 
lenses19. 
Further, autosomal dominant and recessive forms of FEVR (familial exudative 
vitreoretinopathy), which are caused by mutations in Frizzled- 4 (FZD4) and LDL related 
protein 5 (LRP5) in approximately 35% of the patients20,21, resemble the clinical pictures of 
the X-linked diseases12,13,22. Prompted by these findings and the phenotypic similarities 
between Ndph and Fzd4 knockout mice, Xu et al. could provide the first hint for a possible 
cellular function of Norrin. They showed that Norrin is a high affinity ligand of Frizzled-4 
and activates the canonical Wnt/beta-catenin pathway in the presence of LRP5 in cell 
culture23. This pathway eventually leads to transcriptional regulation of target genes under the 
control of TCF/Lef-binding sites. In summary, these data suggest that Norrin has an influence 
on transcriptional regulation of Wnt-target genes, is required for early angiogenic sprouting in 
the retina and the regression of the hyaloid vessel system, and is necessary for the formation 
of deep retinal capillary networks around postnatal day 7 (p7)15. 
 
The main purpose of the experiment reported here was to find differently expressed genes in 
retinae of p7 Ndph knockout mice that are involved in the process of deep plexus formation 
and that could confirm Norrin’s hypothesized role on Wnt target genes in vivo. Our findings 
support a role of Norrin in blood vessel development and provide evidence for a potential 
regulation of new target genes that were not considered so far. However, involvement of the 
Wnt/beta-catenin pathway could not be demonstrated by our experiments. One gene, the 
plasmalemma vesicle associated protein (Plvap), has been characterized in more detail. This 
gene was described as a major structural component of fenestrated blood vessels24, and here 
was found to be up-regulated in the retinal vasculature in the absence of Norrin. Thus, we 
discuss the question whether or not Norrin could also be involved in blood vessel integrity 
and the formation or maintenance of the blood-retina-/blood-brain-barrier. 
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MATERIALS AND METHODS 
Animals 
The Ndph knockout mouse line has been described before by Berger et al.12. Briefly, exon 2 
of the Ndph gene has partially been replaced by homologous recombination with a reverse 
oriented neomycin cassette, resulting in a loss of about half the coding sequence, including 
the signal peptide for protein secretion. The mutation is kept on a C57BL/6 background. 
Genotyping was performed by PCR analysis of tail DNA12. The research was performed in 
accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision 
Research and was approved by the Veterinary Service of the State of Zurich (Switzerland). 
Tissue isolation and RNA preparation 
Wild type and Ndphy/- mice of different developmental stages (p5, p7, p10, p15, p21) were 
sacrificed by cervical dislocation. Five animals of each genotype were prepared and the 
retinae were frozen in liquid nitrogen. Total RNA was extracted using the RNeasy®-Kit 
(Qiagen, Hilden, Germany) according to the manufacturers instructions. DNase digestion was 
applied either directly on-column (p7 samples, RNase-free DNase Set, cat. no. 79254, Qiagen, 
Hilden, Germany), or separately after RNA extraction (RQ1 RNase-free DNase, p/n M610A, 
Promega, Madison, WI, USA). Both retinae of one animal were pooled into one tube of lysis 
buffer and homogenized with an Ultra-Turrax® high-performance disperser (Ika-Werke, 
Staufen, Germany). RNA quality was determined with a NanoDrop ND 1000 (NanoDrop 
Technologies, Delaware, USA) and a Bioanalyzer 2100 (Agilent Technologies, Santa Clara, 
CA, USA). RNA Integrity number of all samples was greater or equal to 9.3. 
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Microarray experiment 
Gene chip expression analysis has been carried out with RNA from p7 retinae (wt: n=5, ko: 
n=5), using the Affymetrix GeneChip® Mouse Genome 430 2.0 array (Affymetrix Inc., Santa 
Clara, CA, USA). On this chip, over 34,000 genes and ESTs are represented by ~45,000 
probe sets. The Microarray experiment, from cDNA preparation to raw data processing, was 
performed at the Functional Genomics Center Zurich. Briefly, total RNA samples (2µg each) 
were reverse-transcribed without additional amplification (one-cycle protocol), purified, 
labeled and hybridized to the chip according to the manufacturer’s instructions. An 
Affymetrix GeneChip Scanner 3000 was used to measure the fluorescence intensity emitted 
by the labeled target.  
Statistical analysis Raw data processing was performed using the Affymetrix GCOS 1.2 
software (Affymetrix Inc., Santa Clara, CA, USA). After hybridization and scanning, probe 
cell intensities were calculated and summarized for the respective probe sets by means of the 
MAS5 algorithm25. To compare the expression values of the genes from chip to chip, global 
scaling was performed, which resulted in the normalization of the trimmed mean of each chip 
to a target intensity (TGT value) of 500 as detailed in the statistical algorithms description 
document of Affymetrix (2002). Quality control measures were considered before performing 
the statistical analysis. Differently expressed genes were calculated with the GeneSpring 7.2 
software (Agilent Technologies, Santa Clara, CA, USA), filtered for presence (per Affymetrix 
presence/absence flags) in four of five samples in either one condition (wt or ko) and then 
subjected to a non-parametric test for differential expression (Mann-Whitney test without 
multiple testing correction (p<0.01), or with Benjamini-Hochberg multiple testing correction 
(p<0.1)). 
Pathway analysis Pathway analysis was conducted with the online tool “Pathway express”, 
which is part of the “Onto-Tools”, hosted by the Wayne State University, Detroit, USA, using 
the default options26. 
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Gene ontology annotations Gene ontology (GO) annotations are used to describe e.g. 
biological process or cellular component of a given gene product. Annotations for the top 
differently expressed genes (Table 3) were obtained from the Database for Annotation, 
Visualization and Integrated Discovery (DAVID) from the National Institute of Health27. 
 
Quantitative reverse transcription-PCR 
Quantitative RT-PCR was performed not only to investigate differential expression during 
development, but also to verify the microarray results. For p7, the same samples as in the 
array experiment were used. Generation of cDNA was accomplished as follows: 1250ng total 
RNA were reverse transcribed in a 20µl reaction, using random hexamers pd(n)6 (Amersham 
Biosciences / GE Healthcare Europe, Otelfingen, Switzerland) and SuperScript III RT 
(Invitrogen, Carlsbad, CA, USA). For expression analysis of Slc38a5 and Mdm2, quantitative 
RT-PCR was conducted using 0.5µM of a forward/reverse primer pair (binding in the area 
that is recognized by the Affymetrix probes; Table 1) and SYBR®-Green PCR Mastermix 
(Applied Biosystems, Foster City, CA, USA). TaqMan® probes and TaqMan® Universal PCR 
Mastermix (Applied Biosystems, Foster City, CA, USA) were used for quantification of Aass, 
Centd3, ApoD, Cldn5, Agtrl1, Adm and Plvap expression (Table 1). In each reaction, 10ng of 
transcribed total RNA were employed (except: Slc38a5 / 100ng). 
Quantitative RT-PCR was carried out in five replicates in an Applied Biosystems PRISM® 
7900HT system using the recommended standard cycling conditions: 45 cycles of 
denaturation (15s/95°C) and annealing/extension (1min/60°C). Gapdh and 18S (TaqMan®) or 
28S (SYBR®-Green) rRNA were used as endogenous controls. Confidence intervals for wild 
type and knockout gene expression were calculated on basis of the mean ∆∆ ct-values at a 
significance level of 95% using Student’s t-test. 
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Gene 5' Primer 3' Primer
Mdm2 AAG ACA GGC TCT CAC TAT TAG CTA TGG TGG GAG TTA AAG GTC TGC CTG AT
Slc38a5 CGA CCT TTG GAT ACC TCA CCT T TGG GTG TAC ATT TCC AGC ATC T
28S rRNA TTG AAA ATC CGC GGG AGA G ACA TTG TTC CAA CAT GCC AG
Gapdh AAC GAC CCC TTC ATT GAC TCC ACG ACA TAC TCA GCA C
Gene TaqMan® probe Gene TaqMan® probe
Aass Mm00497118_m1 Adm Mm00437438_g1
Agtrl1 Mm00442191_s1 Plvap Mm00453379_m1
ApoD Mm00431817_m1 18S rRNA p/n 4308329
Centd3 Mm00551866_m1 Gapdh p/n 4352339E
Cldn5 Mm00727012_s1
 
Table 1 Primers for SYBR®-Green assays and part no. of TaqMan® assays used in this study (Applied 
Biosystems, Foster City, CA, USA). 
 
Immunohistochemical staining and histology  
Cryosections were prepared from male wt and Ndphy/- mice aged p3, p5, p7, p10, p15 and 
p21. Eyes were dissected, fixed for 1h in PBS / 4% para-formaldehyde, washed in PBS and 
cryo-protected in Succrose (30min in 10%, then o/n in 20%) at 4°C. They were embedded in 
Tissue-Tek® O.C.T. Compound (Sakura Finetek, Zoeterwoude, Netherlands), submersed in 
liquid nitrogen, cut into 8µm sections with a Leica Cryostat CM 3050S (Leica, Heerbrugg, 
Switzerland) and transferred onto microscope glass slides. After drying the sections for at 
least 3h, unspecific binding sites were blocked by incubation with 5% normal sheep serum 
(Sigma Aldrich, Steinheim, Germany) in PBST for 1h. Slides were incubated with primary 
antibodies in blocking solution (o/n, 4°C) in a wet chamber. Antiserum concentrations were 
1µg/ml for anti-Plvap/MECA-32 (rat anti-mouse, Developmental Studies Hybridoma Bank) 
and 7µg/ml for anti-Collagen IV (polyclonal Col IV antibody, rabbit anti-mouse, no. 2150-
1470, AbD Serotec/MorphoSys, Oxford, UK). Sections were washed and incubated with 
secondary antibodies in PBS (90min, RT). Cy3™-conjugated anti-rabbit IgG serum (Jackson 
ImmunoResearch Europe, Newmarket, Suffolk, UK) was used at a concentration of 5µg/ml, 
Alexa Fluor® 488-labelled anti-rat IgG/M (no. A11006, Molecular Probes, Leiden, 
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Netherlands) was used at 2µg/ml. Slides were washed a last time and finally mounted in a 
DAPI-containing medium (Vectashield® Mounting Medium for Fluorescence with DAPI H-
1200, Vector Laboratories, Burlingame, CA, USA). Images were taken with an Axioplan 2 
microscope equipped with an AxioCam HRc digital camera (Carl Zeiss MicroImaging, Jena, 
Germany). Contrast in Plvap/AF 488 images was enhanced after acquisition with a photo-
editing program. 
For retinal flatmounts, eyes were dissected and fixed for 15min in PBS/4% para-
formaldehyde. Retinae were removed and post-fixed for additional 15min. After washing in 
PBS, unspecific binding was blocked by 10% normal sheep serum in PBST for 1h. Samples 
were then incubated o/n with the Collagen IV antibody. They were washed six times for 1h in 
PBST and incubated o/n with the secondary Cy3-labeled antibody. After repetition of the 
washing procedure, the retinae were finally flatmounted on microscope slides. 
Sections (8µm) of paraffin-embedded eyes were hematoxylin-eosin stained as described 
elsewhere15 and observed under bright-light illumination. 
 
RESULTS 
In this study, we used the Ndph knockout mouse to investigate molecular pathways involved 
in early angiogenic sprouting in the retina and the formation of deep retinal capillary networks 
at around postnatal day 7 (p7)15. We hypothesized that Norrin is required for these processes, 
probably by transcriptional regulation of Wnt/beta-catenin target genes and/or other pathways. 
 
Retinal morphology at p7 
At p7, conventional microscopy of HE stained retinal sections did not reveal apparent 
differences in the retinal morphology of wild type and Ndph knockout mice (Fig.1A, B). In 
contrast, ColIV immunohistochemistry revealed that the retinal vasculature of the Ndph 
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knockout was strikingly altered, showing an intermediate phenotype to what we earlier 
observed at p5 and p1015. The superficial vessel system appeared much sparser than in the 
wild type, its outgrowth was delayed, and missing vascular sprouts indicated a lacking 
development of deep retinal vessels (Fig. 1C-E). Since we argue that the vascular phenotype 
is the earliest and most obvious retinal defect caused by the absence of Ndph, we used this 
developmental stage to investigate the initial pathologic events on the molecular level, i.e. to 
identify genes involved in the initiation of the deep retinal capillary network by sprouting 
angiogenesis, which may be regulated by Norrin directly or indirectly. 
 
Microarray gene expression analysis 
To identify differently expressed genes in the retina of Ndph knockout mice, we took a global 
gene expression approach using microarrays. The gene chip experiment resulted in 26’817 
expressed probe sets in p7 retinae. Differences in the overall expression levels between 
Ndphy/- and wild type retinae were rather moderate, both in absolute number and fold-change. 
In microarray studies, usually an arbitrary fold-change cut-off of 2.0 has been applied28, still 
resulting in dozens or hundreds of differently expressed genes. Yet, expression changes of 
highly expressed genes may still be biologically relevant despite a fold-change lower than 2.0, 
while weakly expressed transcripts may show a fold-change higher than 2.0 due to their 
greater inherent measurement error28. In this study, we reasoned that a cut-off of 1.6 might 
still be valid considering our use of five biological replicates (instead of the standard three) 
while giving us a decent list of differently expressed genes. 
The list of expressed probe sets was subjected to a non-parametric Mann-Whitney test with 
multiple testing correction (Benjamini-Hochberg, p<0.1). This resulted in a list of 450 probe 
sets (with 10% = 45 false positives), thirty-four of which showed a fold-change of at least 1.6. 
Each of the thirty-four represents a different gene (Table 2), including five currently unknown 
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cDNAs. Sixteen transcripts show an elevated expression in the knockout, while levels of 
eighteen genes are decreased. 
Since only one of these 34 genes (Apcdd1) has been associated with the Wnt-signaling 
pathway so far, we attempted to find evidence for its involvement with a pathway analysis. 
Because the list of 34 genes was too small for this purpose, we subjected the list of expressed 
probe sets to a non-parametric Mann-Whitney test (p<0.01), but this time without multiple 
testing correction and fold-change cut-off. This resulted in a list of 872 probe sets (730 genes 
or ESTs) to be considered differently expressed between wild type and knockout. We then 
performed a pathway analysis based on these 730 genes by utilizing the online tool “Pathway 
express”26. Also here, an involvement of Wnt-signaling was not striking. The five most 
prominent affected pathways were: the MAP-Kinase pathway, focal adhesion, calcium-
signaling, tight junction, and only then, Wnt-signaling (Table 3). Due to the low statistical 
power of this analysis, these results must be treated with caution. While they might provide 
clues for future research activities, they have to be verified first by independent experiments. 
In the study presented here, we decided to concentrate on the list of the 34 most differently 
expressed genes (Table 2). 
As expected for a knockout, the Ndph gene appears in the list of lower expressed genes. 
However, its expression is only decreased by the factor of two. One possible explanation 
could be the general low retinal Ndph expression in the wild type, so the indicated fold-
change could be the result of a measurement error. Second, the knockout is not a complete 
null-allele, but rather lacks most of exon 2, resulting in the loss of about half its coding 
region. Since the probes of the Affymetrix Mouse Genome 430 2.0 array predominantly target 
the 3’-region and a signal was detected in the knockout, it is possible that a transcript 
including this region is present in the retina of Ndphy/- mice. In fact, a ko-allele derived, low 
expressed artificial transcript has been isolated from the brain of Ndphy/- mice. Partial 
sequencing of this transcript revealed that no functional Norrin can be translated from this 
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RNA, as almost half of the open reading frame, including the signal peptide, is missing and 
no start codon is present in the relevant transcript area (data not shown29). 
 
Verification of differential expression by qRT-PCR 
To validate the microarray results, qRT-PCR was performed for three of the most upregulated 
and six of the most downregulated transcripts using the same p7 retina RNA samples that 
were used for the array experiment. Relative quantification values were determined with 18S 
or 28S rRNA and Gapdh (not shown) as endogenous controls. Expression values in general 
seemed to correlate with the microarray results (Fig. 2). Five genes were proven to be 
significantly differently expressed. Three genes showed a decreased expression in the 
knockout: The neutral amino acid transporter Slc38a5 (24x less), apolipoprotein D (ApoD; 
2.4x less) and angiotensin II receptor-like 1 (Agtrl1; 2x less). Increased expression was found 
for the plasmalemma vesicle-associated protein (Plvap; 4.2x higher) and adrenomedullin 
(Adm; 2.7x higher).  
Despite the low fold-change threshold of 1.6 for our microarray statistical analysis, we were 
able to confirm differential expression of more than half the genes examined. 
 
Expression during development 
We further investigated expression for the two most differently expressed verified genes, 
Plvap and Slc38a5, during postnatal retinal development. In addition to p7, qRT-PCR was 
conducted on retinal cDNA from p5, p10, p15 and p21 (Fig. 3). 
Plvap expression in the knockout was significantly increased at every developmental stage in 
comparison to the wild type. The difference increased about one order of magnitude in later 
stages (p15/p21) when compared to the earlier stages (p5-p10) (Fig. 3A). 
Slc38a5 expression was significantly decreased at every developmental stage in the Ndph 
knockout (Fig. 3B). Fold-change was about ten times lower at p5 and p15, about twenty-five 
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times lower at p7 and p10 and about three times lower at p21. Since the Slc38a5 locus is 
located within 8.6 Mb from the Ndph locus, we investigated whether the observed difference 
was caused by a different genetic background, because the knockout Ndph allele is derived 
from the 129P2 mouse strain, which has then been backcrossed to the C57BL/6 background. 
We could not exclude a background effect by analysis of a genetic marker inside the Slc38a5 
locus (rs13483703), since it indicated the 129P2 allele at this position. Thus, we studied the 
expression of Slc38a5 by additional qRT-PCR on p7 retinae of 129P2 wild type males and 
found similar levels as in the C57BL/6 wild type group (data not shown). Consequently, we 
excluded an influence of the genetic background on the expressivity of Slc38a5. 
In summary, these developmental studies, which were performed on array-experiment 
independent RNA samples, added additional proof to the obtained microarray gene expression 
data.  
 
Immunohistological staining of Plvap 
As gene expression differences do not always reflect consequences at the protein level, 
immunohistochemistry was also performed for Plvap at all developmental stages that have 
been investigated on the transcript level (plus p3 in addition). Eye cryosections of Ndphy/- and 
wild type mice were co-immunolabeled with antibodies directed against Plvap, a high specific 
marker for endothelial cells (MECA-32)30, and collagen type IV (ColIV) to visualize the 
vascular beds23 (Figure 4). In all stages investigated (p3-p21), ColIV staining has been 
observed in the choroid and the superficial retinal vasculature of both genotypes. Vessels of 
the inner retina, located in the outer and inner plexiform layers, were detected in later stages 
in the wild type, but not the knockout retina, as has been described before13,15.  
Plvap was localized similarly to the choroidal vessel system in both wild type and knockout 
animals at all investigated developmental stages. However, the Plvap staining pattern of the 
retinal vasculature differed considerably. In the wild type, labeling was very faint at most. 
 Differential gene expression in Ndph knockout mice in retinal development    15 
Traces were observed in the superficial network at p3, but not in later stages, and the deep 
vessel system appeared to be slightly stained only at p10 (Figure 4, arrows). In contrast, Plvap 
staining in the knockout was detected as early as p3, but even more obvious and with 
increasing intensity at all later stages.  
Taken together, these data show that Plvap expression in Ndphy/- retinae is increased not only 
on transcript, but also on protein level, which in particular seems to be confined to the retinal 
vasculature. 
 
DISCUSSION 
 
Norrin and the role of Wnt-signaling 
When Norrin has been shown to bind to the Wnt-receptors Frizzled-4 and LRP-523, it was 
suggested that signaling occurs through the canonical Wnt/beta-catenin pathway. 
Surprisingly, our study suggested only one gene among the most differently transcribed genes 
besides Ndph to be associated with this pathway: Adenomatosis polyposis coli down-
regulated 1 (Apcdd1). This does not necessarily mean that Norrin is not exerting its function 
over binding to Wnt-receptors – but it may imply that Norrin does not work primarily as a 
transcriptional regulator via the canonical Wnt/beta-catenin signaling. However, this 
conclusion relies heavily on the number of currently known Wnt target genes, and on the 
assumption that this signaling actually occurs in p7 retinae - so it is still possible that this 
pathway is more prominent at another developmental stage. Furthermore, since we were not 
able to detect expression differences of two major angiogenesis-related genes albeit they have 
been shown to be regulated by Wnt-signaling (Tie-2/Tek31 and Vegfa32), it is possible that 
Norrin has a direct role in controlling expression of Wnt-target genes in a spatially and 
temporally restricted manner which was not detectable by our experimental approach. 
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On the other hand, we were able to confirm differential expression of five genes that so far 
were not shown to be Wnt-targets. 
 
Plvap as an early indicator for vascular permeability 
Our results suggest an early involvement of Plvap (plasmalemma vesicle-associated protein) 
in the pathogenesis of NDP-related retinopathies. We found increased mRNA expression of 
Plvap throughout development (Fig. 3A) and also conclusive differences between immuno-
stained cryosections of wild type and Ndphy/- mice (Figure 4). Plvap is endothelial cell 
specific, and has been described as integral membrane glycoprotein associated with the 
stomatal diaphragms of caveolae, transendothelial channels, vesiculo-vacuolar organelles and 
the diaphragms of endothelial fenestrae24,33. Enhanced prevalence of endothelial fenestrae 
might result in reduced vascular integrity. Both have been observed in retinae of Ndphy/- mice 
as soon as p1413,15. Plvap expression further has been shown to be negatively correlated with 
the differentiation of the blood-brain-barrier30. Hence, elevated expression of Plvap may 
indicate enhanced vascular permeability and break-down of the blood-retina-barrier. It has 
previously been proposed that blood vessel leakiness is a result of hypoxia-driven VEGF 
(vascular endothelial growth factor A) upregulation15 and thus is a secondary effect due to 
low oxygen supply. Interestingly, Plvap itself has been suggested to be a VEGF target34, 
rendering a correlation between vessel leakiness and Plvap more likely. Thus, elevated 
expression of Plvap in later developmental stages (p15 onwards; Fig. 3A, 4), when a 
malformed/underdeveloped vasculature causes a pathologic hypoxic condition in the retina, 
was not surprising. Development of the superficial vessel system, however, is driven by a 
physiological hypoxia through induction of a periphery-to-center gradient of VEGF14. 
Noteworthy, this hypoxia-driven VEGF expression does not, or only marginally, yield visible 
Plvap expression in the wild type situation that is detectable by immunohistochemistry. 
Therefore, we think that an increased Plvap expression in early developmental stages (p3-p10; 
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Fig. 3A, 4) of Ndphy/- mice is not secondary due to low oxygen supply and subsequent VEGF 
upregulation, but rather due to a lack of Norrin that may have an important influence on 
vascular development. This is supported by the observation that Plvap upregulation is not 
solely dependent on hypoxia or VEGF, but is also triggered by other activation of the Erk1/2 
MAPK pathway35. In addition, also fenestrae induction has been shown to be VEGF-
independent, as it is regulated through cytoskeletal remodeling by actin depolymerization36. 
However, we could not detect differences in total- and phosphorylated ERK1/2 MAP-kinase 
levels on Western blots with retinal protein extracts from p7 Ndphy/- wild type and knockout 
animals so far (data not shown). Additionally, differences in Plvap expression may be due to a 
mechanism of endothelial cells to compensate the impaired blood vessel development, 
because evidence has been provided before that Plvap might have a role in angiogenesis37. 
Thus, it remains to be shown whether a possible mode of action for Norrin, besides 
transcriptional regulation via the Wnt/β-catenin pathway, might be a direct modulation of the 
microtubule cytoskeleton38 or Plvap itself. While we are aware of these alternatives, we 
hypothesize that transient Plvap expression and fenestration occur during maturation of the 
retinal vasculature and that Norrin signaling is possibly required for its suppression. This 
might be indicated by the faint staining of the superficial and deep vasculature in the wild 
type, which was only observed during early development of the respective network (p3 & 
p10), and the retinal expression pattern in the Ndphy/- knockout. Since mRNA and protein 
levels in the knockout have been higher at each developmental stage examined, Norrin might 
act as a suppressor of Plvap expression, and thus may be involved in sprouting angiogenesis 
as well as in the formation and maintenance of the blood-retina- or blood-brain-barrier. 
 
Differential gene expression reflects impaired blood vessel development 
Besides Plvap, we were able to confirm differential expression of four more genes. All but 
one of them seem to emphasize Norrin’s hypothetical role in blood vessel development. 
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Agtrl1 (angiotensin II receptor-like 1) is a venous marker39 that has been shown to be 
important for retinal angiogenesis40. Therefore, its two fold reduction correlates well with the 
observed retinal phenotype of the Ndph knockout mouse. However, we cannot exclude that 
this decreased expression is merely an indicator for the already reduced overall vessel density 
or, considering the venous/capillary nature of the deep vessel system14, a lack of development 
of this particular network. The same applies to the 2.4x reduction of ApoD (apolipoprotein D). 
Nevertheless, ApoD could be implicated in the observed angiogenic defect of Ndphy/- mice, 
because it has been reported to stimulate proliferation and migration of vascular smooth 
muscle cells41, probably through modulation of the cellular response to Pdgf-bb42. ApoD 
expression was suggested to be induced by PDGF-BB itself43. Interestingly, Pdgfb and Pdgfrb 
expression have been shown to be decreased in Ndphy/- mice in early stages (p5/p10) before15, 
which could indicate reduced angiogenic activity. Although Pdgfb has been shown to be 
regulated by VEGF43, Vegfa levels were not different at p5 and even higher at p1015, 
suggesting an alternative, VEGF-independent transcriptional regulation of Pdgfb, and thus 
ApoD, in Ndph knockout mice. The possibility of a functional relationship between Norrin 
and ApoD might be supported by the finding of co-expression of these two genes in disease-
affected organs. APOD has been shown to be upregulated in human endometrium during 
implantation44, a process that is disturbed in female homozygous Norrin knockout mice45. 
Further, ApoD expression was also reported in the inner ear, another affected organ in Norrie 
disease patients and mice46, where it has been suggested to be implicated in cochlear fluid 
homeostasis47. Taken together, Norrin may influence angiogenesis either by direct 
transcriptional regulation of ApoD, or indirectly via Vegfa-independent regulation of Pdgf-β. 
Nearly three times elevated transcript levels in the knockout were observed for 
adrenomedullin (Adm) by quantitative RT-PCR. It has been described to be a hypoxia induced 
vasodilating peptide48 that might have a vascular protective function49. Adm probably exerts 
its protective role through a reduction of oxidative stress50 and has further been shown to 
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inhibit vascular remodeling51. It is tempting to speculate that elevated expression of Adm itself 
could lead to a developmental defect due to its anti-angiogenic properties, and that improper 
transcriptional regulation might be the cause for it. Hence, also differential expression of Adm 
correlates well with the Ndphy/- phenotype. 
Surprisingly, and in contrast to the other genes discussed here, the gene most differently 
expressed has not directly been linked to angiogenesis. Slc38a5 (solute carrier familiy 38, 
member 5), which showed a twenty-five times decreased expression at p7 in Ndphy/- mice 
(Fig. 3B), has been reported to be a main glutamine transporter in retinal Müller cells (system 
N2)52. It therefore may play an important role for the neuronal signal transduction through 
regulation of the glutamate/glutamine household. Its decreased expression in Ndphy/- mice 
may indicate an involvement of Müller glia cells as a target of Norrin signaling. This may be 
reflected by the reduced synaptic activity that has been observed by ERG measurements in 
later stages53 and is consistent with our observation that Slc38a5 expression is decreased at 
every developmental stage investigated, including the rather mature p21 (Fig. 3B). Besides 
their importance for neural function, Müller cells also play a role as guidance structures for 
the developing deep retinal vasculature14. As such, one could speculate that communication 
between Müller cells and blood vessels might be disturbed in Norrin knockout mice. 
Interestingly, it has been reported earlier that blood vessels of the ganglion cell layer are 
frequently not surrounded by glia in p14 Ndphy/- mice13. However, another possible 
explanation for reduced Slc38a5 expression could be a secondary, neuroprotective response of 
Müller cells to oxidative stress. While this seems to be a likely mechanism at later, hypoxic 
stages in development (p15/p21), we think a ten-fold decreased expression of Slc38a5 at p5 is 
unlikely to be exclusively the result of hypoxia-induced neuroprotection (Fig. 3B). Besides 
this, no evidence for hypoxia at p5 has been provided so far: Western blots for the glial stress 
marker GFAP and the hypoxia-inducible factor 1-alpha (Hif1a) were shown to be similar up 
to p15 and p10, respectively, and no significant expression differences could be found for 
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VEGF15 at this stage. But Slc38a5 is not only expressed in the retina: it is also abundant in 
astrocytic end feet in the brain, the highest levels being found in neocortex, hippocampus, 
striatum and the cerebellum54. 
Thus, differential expression of this molecule might be a hint for a possible pathogenic 
mechanism also in the brain that could be associated with the mental retardation phenotype of 
ND. Noteworthy in this context, a microdeletion including SLC38A5 and the neighboring 
FTSJ1 has been found in three brothers with moderate to severe mental retardation55.  
 
Conclusion 
Consistent with data obtained from other developmental stages15, our examination of p7 Ndph 
knockout mice showed insufficient retinal capillarization and lack of deep vessel formation. 
For the first time, vascular permeability has not been observed only in later, nearly adult 
stages, but was noted throughout development, as indicated by elevated mRNA and protein 
expression data for Plvap. 
Because of the early developmental stage investigated here and the lack of neovascularization 
in later stages, we tend to consider a role of VEGF itself in the early pathogenesis of NDP-
related diseases rather unlikely and ask whether Norrin instead might modulate the cellular 
response to VEGF. Norrin’s hypothetical role as a transcriptional regulator of Wnt/β-catenin 
target genes is not obvious from the array experiment. However, our recent and previous 
studies suggest that Norrin is important for retinal angiogenesis. Here, we could identify 
several genes probably implicated in blood vessel development that may be transcriptionally 
regulated by Norrin, directly or indirectly. These genes include Agtrl1, ApoD, and Adm, while 
Slc38a5 might represent an interesting candidate with regard to future research of aberrant 
neuronal development and the massive reactive gliosis that may be the basis for the often 
described pseudogliomas in ND patients56. Finally, due its proposed role in angiogenesis and 
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blood vessel integrity24,37, our findings suggest an important contribution of Plvap to the 
pathogenesis of Norrin-associated diseases. 
 
ACKNOWLEDGMENTS 
The a-Plvap/MECA-32 monoclonal antibody developed by Eugene C. Butcher was obtained 
from the Developmental Studies Hybridoma Bank developed under the auspices of the 
NICHD and maintained by The University of Iowa, Department of Biological Sciences, Iowa 
City, IA 52242. 
We would like to thank Marzanna Künzli from the Functional Genomics Center Zurich for 
conducting the microarray experiment from reverse transcription to raw data processing. 
 
 
22    Schäfer et al. 
 
Retinae of p7 wild type and Ndphy/- mice 
 
 
Figure 1 Retinae of p7 Ndphy/- mice in comparison to wild type. (A,B) Hematoxylin-eosin (HE) stained central 
sections of paraffin embedded retinae. No obvious difference in retinal organization could be detected. (C,D) 
Immunofluorescence images from retinal flatmounts. Images compiled from a Z-Stack of pictures acquired with 
a Zeiss ApoTome™. To visualize the retinal vasculature, an antibody against Collagen-IV was used. In the wild 
type p7 retina, deeper networks start to develop from veins and capillaries, but not arteries, as has been shown by 
other authors14 (arrowheads). In contrast, outgrowth of the superficial capillary network in the knockout is 
delayed, appears to be much sparser, and no developing deeper network could be detected. (E,F) Higher 
magnification of ApoTome™ images from c,d. Superficial vasculature is shown in red, deep vasculature in 
green. GCL: ganglion cell layer; IPL: inner plexiform layer; INL: inner nuclear layer; OPL: outer plexiform 
layer; ONL: outer nuclear layer; A: artery; V: vein 
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Verification of array results 
 
Figure 2 Transcriptional analysis of selected genes in retinae of Ndphy/- knockout (n=5) and wild type (n=5) 
mice. The average expression value of the wild type group was set to 1. Error bars indicate the confidence 
interval at a significance level of 95% (p<0.05). Quantitative RT-PCR results from p7 retinae for genes that 
showed increased or decreased expression in the array experiment are depicted in (A) or (B), respectively. (A) 
Expression of Adrenomedullin (Adm; 2.7x) and the gene for the Plasmalemma vesicle associated protein (Plvap; 
4.2x) is significantly increased at p7. (B) The neutral amino acid transporter Slc38a5 (25x), Apolipoprotein D 
(ApoD; 2.4x) and Angiotensin II receptor-like 1 (Agtrl1; 2x) show significantly decreased expression at p7. 
Significant difference in Claudin 5 (Cldn5) expression is borderline. 18S / 28S rRNA were used as endogenous 
controls. 
 
Relative expression in development 
 
Figure 3 Transcriptional analysis of the two most differently expressed verified genes in retinae of Ndphy/- 
knockout (n=5) and wild type (n=5) mice. The average expression value of the wild type group was set to 1. 
Error bars indicate the confidence interval at a significance level of 95% (p<0.05). (A) Plvap expression is 
significantly increased at every developmental stage from p5 to p21. Difference between wild type and knockout 
increases about one order of magnitude in later stages (p15/p21) when compared to the earlier stages (p5-p10). 
Insert shows expression data for p5-p10 in a different scale. (B) Slc38a5 expression is significantly decreased at 
every developmental stage.  Variability of wild type expression is higher in later stages (p10-p21) than in early 
stages (p5, p7). Following endogenous controls were used: (A): 18S rRNA (B): Gapd 
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Figure 4 Immunofluorescence images of retinal cryosections of Ndphy/- mice in comparison to wild type. For 
each one of the indicated developmental stages (p3, p5, p7, p10, p15 and p21), co-immunolabeling with 
antibodies directed against Plvap (AF488; green) and Collagen-IV (Cy3; red) has been performed. Collagen-IV 
localizes to the extracellular matrix of endothelial cells and serves as a marker for blood vessels. In all stages 
investigated, staining has been observed in the choroid (CV, below the RPE) and the superficial retinal 
vasculature (RV, inside the RGC/nerve fibre layer). From p10 onwards, blood vessels of the secondary, deep 
retinal vasculature were detected in the OPL in the wild type, but not the knockout retina. In addition, at p15 and 
p21, the tertiary, intermediate vessel system in the IPL can be seen in the wild type. Plvap localizes to the 
choroid vessel system (CV) in both wild type and knockout at all developmental stages. Interestingly, Plvap 
expression has also been detected in the retinal vasculature (RV) of the knockout animals beginning at p3 and 
more intense over time. In contrast, the retinal vasculature of the wild type is not, or only very weakly, labeled 
by the Plvap antibody. In the superficial vessel network, staining in the wild type could only be detected at p3 
(arrow), but not in later stages. At p10, slight staining of the deep vessel system was observed (arrows). RV: 
superficial / deep retinal vasculature; CV: Choroid; RGC: retinal ganglion cell layer; IPL: inner plexiform layer; 
INL: inner nuclear layer; OPL: outer plexiform layer; ONL: outer nuclear layer; RPE: retinal pigment epithelium. 
 
26    Schäfer et al. 
 
 
Rank Pathway Name Impact Factor #Genes in Pathway
#Input Genes 
in Pathway
#Pathway 
Genes on Chip
%InputGenes 
in Pathway
1 MAPK signaling pathway 23.79 233 11 231 1.51
2 Focal adhesion 20.00 156 7 143 0.96
3 Calcium signaling pathway 18.93 180 8 172 1.10
4 Tight junction 13.67 125 7 114 0.96
5 Wnt signaling pathway 12.77 141 6 139 0.82
Genes mapped to pathways: 75
cDNAs: 868
Top 5 involved pathways
 
Table 3 Results of a pathway analysis performed with the online tool “Pathway express”, which is part of the 
“Onto-Tools”, hosted by the Wayne State University, Detroit, USA26. Only 10% of the input genes could be 
mapped to a pathway based on the KEGG Pathway Database. 
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